(Q37994645)

26 August 2017

title

A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics (English)

1 reference

26 August 2017

0 references

C Shing

4

0 references

author name string

L Vitetta

1

1 reference

26 August 2017

D Briskey

2

1 reference

26 August 2017

E Hayes

3

1 reference

26 August 2017

J Peake

5

1 reference

26 August 2017

language of work or name

1 reference

18 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

20

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

251-266

1 reference

https://scigraph.springernature.com/pub.10.1007/s10787-012-0126-8

26 August 2017

exact match

0 references

cites work

The effect of infections on susceptibility to autoimmune and allergic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Prebiotics and synbiotics in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The immune system and the gut microbiota: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Health benefits of probiotics: are mixtures more effective than single strains?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Use of probiotics for prevention of radiation-induced diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Sensor molecules in intestinal innate immunity against bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics in the treatment of human inflammatory bowel diseases: update 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics in man and animals

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

21 January 2018

12 December 2020

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics in infective diarrhoea and inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics for prevention and treatment of diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Gut microbiota and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Bacterial contributions to mammalian gut development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Immune adaptations that maintain homeostasis with the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Regulatory B-cell induction by helminths: implications for allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Regulation of regulatory T cells: role of dendritic cells and toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics and prebiotics in periodontal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Irritable bowel syndrome, gut microbiota and probiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Evolution of mammals and their gut microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics in inflammatory bowel diseases and associated conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Maternal antibodies, childhood infections, and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics: a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A microbial symbiosis factor prevents intestinal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Helicobacter pylori infection and childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The gut flora as a forgotten organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

How Toll-like receptors signal: what we know and what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Toll-dependent control mechanisms of CD4 T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The enteric microbiota in the pathogenesis and management of constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Host-recognition of pathogens and commensals in the mammalian intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Beneficial health effects of low-digestible carbohydrate consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The tight junction: a multifunctional complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The hygiene hypothesis: an evolutionary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Mucosal flora in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The physiological relevance of the intestinal microbiota--contributions to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

The germless theory of allergic disease: revisiting the hygiene hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

A mixture ofEscherichia coli(DSM 17252) andEnterococcus faecalis(DSM 16440) for treatment of the irritable bowel syndrome - A randomized controlled trial with primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0126-8

Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial

21 January 2018

1 reference

12 December 2020

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

12 December 2020

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

1 reference

12 December 2020

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of 25 weeks probiotic supplementation on immune function of HIV patients

1 reference

12 December 2020

The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives

1 reference

12 December 2020

Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome

1 reference

12 December 2020

The response of the lymphatic tissue to the microbial flora. Studies on germfree mice

1 reference

12 December 2020

Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus

1 reference

12 December 2020

Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis

1 reference

12 December 2020

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

1 reference

12 December 2020

Probiotics affect the clinical inflammatory parameters of experimental gingivitis in humans

1 reference

12 December 2020

A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Probiotics for preventing acute upper respiratory tract infections

1 reference

12 December 2020

Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects

1 reference

12 December 2020

Probiotics, prebiotics, and synbiotics

1 reference

12 December 2020

Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria

1 reference

12 December 2020

Inflamed gut mucosa: downstream of interleukin-10.

1 reference

12 December 2020

Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution

1 reference

12 December 2020

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota

1 reference

12 December 2020

Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure

1 reference

12 December 2020

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.

1 reference

12 December 2020

Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial.

1 reference

12 December 2020

Significance of the discovery of the effects of cortisone on rheumatoid arthritis

1 reference

12 December 2020

An evidence-based systematic review on medical therapies for inflammatory bowel disease

1 reference

12 December 2020

Systematic review of randomised controlled trials: probiotics for functional constipation

1 reference

12 December 2020

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity--a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Helicobacter pylori and probiotics

1 reference

12 December 2020

Probiotic bacteria: legislative framework-- requirements to evidence basis

1 reference

12 December 2020

Probiotics and oral health effects in children

1 reference

12 December 2020

Probiotics and prebiotics: effects on diarrhea

1 reference

12 December 2020

Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study

1 reference

12 December 2020

Clinical utility of probiotics in inflammatory bowel disease.

1 reference

12 December 2020

Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms

1 reference

12 December 2020

10.1007/S10787-012-0126-8

Identifiers

DOI

1 reference

26 August 2017

1 reference